TP53 and cancer: This indicates that loss of apoptotic function, cell cycle arrest/cell senescence and ZMAT3-regulated alternative splicing or not yet identified functions of ZMAT3 contribute to the tumour suppressive function of TRP53 in both haematological and solid cancers, with the combination of the genes lost determining cancer type.